Back to top
more

Bruker (BRKR)

(Real Time Quote from BATS)

$62.17 USD

62.17
75,685

-1.15 (-1.82%)

Updated Sep 11, 2024 10:20 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (94 out of 250)

Industry: Instruments - Scientific

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View Up

by Zacks Equity Research

Year-over-year improvement in segmental revenues in Q2 across all geographies exceeds Illumina's (ILMN) expectations.

Insulet (PODD) Q2 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research

Insulet (PODD) reports better-than-expected revenues for second-quarter 2021 on strong performance of Omnipod, both in U.S. and international markets.

    Tandem Diabetes (TNDM) Q2 Earnings Rise Y/Y, Sales View Up

    by Zacks Equity Research

    Tandem Diabetes (TNDM) reports better-than-expected revenues for second quarter 2021 on strong domestic and international pump shipments driving the top line.

    Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Grow

    by Zacks Equity Research

    Amedisys (AMED) reports better-than-expected earnings for the second quarter with strong performance in Home Health and Hospice segments.

    Bruker (BRKR) Q2 Earnings Beat Estimates, 2021 Guidance Up

    by Zacks Equity Research

    Bruker (BRKR) reports better-than-expected revenues for the second quarter of 2021 on strong segmental performance driving the top line.

    Bruker (BRKR) Q2 Earnings and Revenues Top Estimates

    by Zacks Equity Research

    Bruker (BRKR) delivered earnings and revenue surprises of 10.00% and 6.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

    Qorvo (QRVO) to Report Q1 Earnings: What's in the Cards?

    by Zacks Equity Research

    Qorvo's (QRVO) fiscal first-quarter results are likely to reflect continued strength in its 5G mobile products and Wi-Fi 6 devices, and increased demand for defense solutions.

    Bruker (BRKR) Hits Fresh High: Is There Still Room to Run?

    by Zacks Equity Research

    Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Microchip (MCHP) to Report Q1 Earnings: What's in the Cards?

    by Zacks Equity Research

    Microchip's (MCHP) fiscal first-quarter results are likely to reflect robust uptake of microcontrollers amid uptick in demand across automotive, consumer, industrial, and medical end-markets.

    IPG Photonics (IPGP) to Post Q2 Earnings: What to Expect?

    by Zacks Equity Research

    IPG Photonics' (IPGP) Q2 results are likely to reflect momentum in new end-markets and fiber lasers for urological and dental procedures.

    ON Semiconductor (ON) to Report Q2 Earnings: What's in Store?

    by Zacks Equity Research

    ON Semiconductor's (ON) Q2 revenues are expected to have benefited from recovery in automotive and industrial sector.

    FLEX Q1 Earnings and Revenues Surpass Estimates, Up Y/Y

    by Zacks Equity Research

    Flex (FLEX) Q1 results reflect continued strength in the Agility Solutions and Reliability Solutions segments.

    Should You Buy Bruker (BRKR) Ahead of Earnings?

    by Zacks Equity Research

    Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

    Ultra Clean (UCTT) to Report Q2 Earnings: What's in Store?

    by Zacks Equity Research

    Ultra Clean's (UCTT) Q2 results are likely to reflect solid demand for its semiconductor products and services, along with an expanding clientele.

    MKS Instruments (MKSI) Q2 Earnings Top Estimates, Revenues Up

    by Zacks Equity Research

    MKS Instruments' (MKSI) Q2 results benefit from strength in the semiconductor market and recovery in advanced market revenues.

    Cognizant's (CTSH) Q2 Earnings Beat, Revenues Increase Y/Y

    by Zacks Equity Research

    Cognizant's (CTSH) second-quarter 2021 results reflect robust performance across segments including Healthcare, Communications, Media and Technology.

    Facebook's (FB) Q2 Earnings Beat Estimates, Revenues Up Y/Y

    by Zacks Equity Research

    Facebook's (FB) second-quarter 2021 performance gains from robust ad revenues and user-base expansion in international markets.

    Arista (ANET) to Report Q2 Earnings: Is a Beat in the Offing?

    by Zacks Equity Research

    Solid demand for cloud networking solutions, technological innovations and considerable top-line growth are likely to have aided Arista's (ANET) earnings in the second quarter of 2021.

    Can Bruker (BRKR) Keep the Earnings Surprise Streak Alive?

    by Zacks Equity Research

    Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    Amphenol (APH) Q2 Earnings Beat Estimates, Revenues Rise Y/Y

    by Zacks Equity Research

    Amphenol's (APH) Q2 results reflect robust growth in the automotive, industrial, military and broadband end-markets.

    Apple (AAPL) Q3 Earnings Beat, iPhone Strength Aids Top Line

    by Zacks Equity Research

    Apple's (AAPL) third-quarter fiscal 2021 results reflect robust performance of iPhone and Services segments.

    MSCI Q2 Earnings and Revenues Beat Estimates, Shares Up

    by Zacks Equity Research

    MSCI's second-quarter 2021 results benefit from strong growth in recurring subscription revenues and asset-based fees.

    Silicon Motion (SIMO) to Post Q2 Earnings: What to Expect?

    by Zacks Equity Research

    Silicon Motion's (SIMO) second-quarter results are likely to benefit from continued momentum in SSD controller sales, as well as healthy sales of eMMC and UFS controllers.

    Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    by Zacks Equity Research

    Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    Amphenol (APH) to Report Q2 Earnings: What's in the Cards?

    by Zacks Equity Research

    Amphenol's (APH) second-quarter 2021 results are likely to reflect benefits from a diversified business model and accretive acquisitions.